The total return over the past 12 months is -36.32% vs. +16.94% for the S&P 500. So far it's up -40.28% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (36.32%) | +34.49% | (5.73%) | +0.44% | N/A | N/A |
| Total Return CAGR | (36.32%) | +34.49% | (5.73%) | +0.44% | N/A | N/A |
| Revenue CAGR | (8.14%) | (1.58%) | +10.03% | +40.29% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Ocular Therapeutix, Inc. (OCUL)
| Year | Start price | End price | OCUL Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $12.14 | $7.25 | (40.28%) | +14.51% | (54.79%) |
| 2025 | $8.54 | $12.14 | +42.15% | +17.72% | +24.43% |
| 2024 | $4.46 | $8.54 | +91.48% | +24.89% | +66.59% |
| 2023 | $2.81 | $4.46 | +58.72% | +26.19% | +32.53% |
| 2022 | $6.97 | $2.81 | (59.68%) | (18.17%) | (41.51%) |
| 2021 | $20.70 | $6.97 | (66.33%) | +28.74% | (95.07%) |
| 2020 | $3.95 | $20.70 | +424.05% | +18.37% | +405.68% |
| 2019 | $3.98 | $3.95 | (0.75%) | +31.22% | (31.97%) |
| 2018 | $4.45 | $3.98 | (10.56%) | (4.56%) | (6.00%) |
| 2017 | $8.37 | $4.45 | (46.83%) | +21.70% | (68.53%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
